Literature DB >> 9469840

Transcriptional interference perturbs the binding of Sp1 to the HIV-1 promoter.

I H Greger1, F Demarchi, M Giacca, N J Proudfoot.   

Abstract

Transcriptional interference between adjacent genes has been demonstrated in a variety of biological systems. To study this process in RNA polymerase II (pol II) transcribed genes we have analysed the effect of transcription on tandem HIV-1 promoters integrated into the genome of HeLa cells. We show that transcriptional activation at the upstream promoter reduces transcription from the downstream promoter, as compared with basal transcription conditions (in the absence of an activator). Furthermore, insertion of a strong transcriptional termination element between the two promoters alleviates this transcriptional interference, resulting in elevated levels of transcription from the downstream promoter. Actual protein interactions with the downstream (occluded) promoter were analysed by in vivo footprinting. Binding of Sp1 transcription factors to the occluded promoter was reduced, when compared with the footprint pattern of the promoter protected by the terminator. This suggests that promoter occlusion is due to disruption of certain transcription factors and that it can be blocked by an intervening transcriptional terminator. Chromatin mapping with DNase I indicates that a factor binds to the termination element under both basal and induced conditions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9469840      PMCID: PMC147389          DOI: 10.1093/nar/26.5.1294

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  38 in total

1.  A poly(A) addition site and a downstream termination region are required for efficient cessation of transcription by RNA polymerase II in the mouse beta maj-globin gene.

Authors:  J Logan; E Falck-Pedersen; J E Darnell; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Transcriptional interference and termination between duplicated alpha-globin gene constructs suggests a novel mechanism for gene regulation.

Authors:  N J Proudfoot
Journal:  Nature       Date:  1986 Aug 7-13       Impact factor: 49.962

3.  The terminus of SV40 DNA replication and transcription contains a sharp sequence-directed curve.

Authors:  C H Hsieh; J D Griffith
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

4.  A functional mRNA polyadenylation signal is required for transcription termination by RNA polymerase II.

Authors:  S Connelly; J L Manley
Journal:  Genes Dev       Date:  1988-04       Impact factor: 11.361

Review 5.  Transcriptional activation: a complex puzzle with few easy pieces.

Authors:  R Tjian; T Maniatis
Journal:  Cell       Date:  1994-04-08       Impact factor: 41.582

6.  Promoter occlusion: transcription through a promoter may inhibit its activity.

Authors:  S Adhya; M Gottesman
Journal:  Cell       Date:  1982-07       Impact factor: 41.582

7.  Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis.

Authors:  B R Cullen; P T Lomedico; G Ju
Journal:  Nature       Date:  1984 Jan 19-25       Impact factor: 49.962

8.  Synthesis of a gene for the HIV transactivator protein TAT by a novel single stranded approach involving in vivo gap repair.

Authors:  S E Adams; I D Johnson; M Braddock; A J Kingsman; S M Kingsman; R M Edwards
Journal:  Nucleic Acids Res       Date:  1988-05-25       Impact factor: 16.971

9.  Transcription interferes with elements important for chromosome maintenance in Saccharomyces cerevisiae.

Authors:  M Snyder; R J Sapolsky; R W Davis
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

10.  Alpha-thalassaemia caused by a poly(A) site mutation reveals that transcriptional termination is linked to 3' end processing in the human alpha 2 globin gene.

Authors:  E Whitelaw; N Proudfoot
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  63 in total

1.  Antisense promoter of human L1 retrotransposon drives transcription of adjacent cellular genes.

Authors:  M Speek
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  Balancing transcriptional interference and initiation on the GAL7 promoter of Saccharomyces cerevisiae.

Authors:  I H Greger; A Aranda; N Proudfoot
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

3.  Transcriptional interference by independently regulated genes occurs in any relative arrangement of the genes and is influenced by chromosomal integration position.

Authors:  Susan K Eszterhas; Eric E Bouhassira; David I K Martin; Steven Fiering
Journal:  Mol Cell Biol       Date:  2002-01       Impact factor: 4.272

4.  3'-end formation of baculovirus late RNAs.

Authors:  J Jin; L A Guarino
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

5.  Transcription of the human U2 snRNA genes continues beyond the 3' box in vivo.

Authors:  P Cuello; D C Boyd; M J Dye; N J Proudfoot; S Murphy
Journal:  EMBO J       Date:  1999-05-17       Impact factor: 11.598

6.  A mutation in GRS1, a glycyl-tRNA synthetase, affects 3'-end formation in Saccharomyces cerevisiae.

Authors:  C Magrath; L E Hyman
Journal:  Genetics       Date:  1999-05       Impact factor: 4.562

7.  Promoter competition as a mechanism of transcriptional interference mediated by retrotransposons.

Authors:  Caroline Conte; Bernard Dastugue; Chantal Vaury
Journal:  EMBO J       Date:  2002-07-15       Impact factor: 11.598

Review 8.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

9.  The HTLV-1 hbz antisense gene indirectly promotes tax expression via down-regulation of p30(II) mRNA.

Authors:  Gunjan Choudhary; Lee Ratner
Journal:  Virology       Date:  2010-12-21       Impact factor: 3.616

10.  Transcriptional interference among the murine beta-like globin genes.

Authors:  Xiao Hu; Susan Eszterhas; Nicolas Pallazzi; Eric E Bouhassira; Jennifer Fields; Osamu Tanabe; Scott A Gerber; Michael Bulger; James Douglas Engel; Mark Groudine; Steven Fiering
Journal:  Blood       Date:  2006-10-31       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.